Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
KLAC$129.76-19.89(-13.29%)KLA Declares Regular Cash Dividend4:30:14 PM ETKO$95.75-0.13(-0.14%)DRIVX Moves Toward Final Presale Stage, Unveils Fleet Expansion and Transparent Vesting Strategy4:19:08 PM ETCRWD$217.00-23.98(-9.95%)Why CrowdStrike and cybersecurity stocks got crunched in Thursday's rout4:12:00 PM ETLRCX$192.19-29.09(-13.15%)Lam Research Corporation Announces $25 Billion Share Repurchase Authorization and Declares Quarterly Dividend4:05:00 PM ETSKHY$124.76-18.32(-12.80%)Why SK Hynix Plunged Today4:01:39 PM ETNVDA$182.13-18.16(-9.07%)Is Nvidia Still a Millionaire-Maker Stock?3:51:00 PM ETTSLA$342.08-43.10(-11.19%)SpaceX and Tesla Stock Plunges Have Wiped About $450 Billion in Value Since the Midterms. Is It Time to Buy?3:43:35 PM ETGOOGL$280.75-8.28(-2.86%)Google plans $17 billion Wyoming data center amid rising threats of curbs3:43:13 PM ETNOW$101.20-7.71(-7.08%)Arista Networks vs. ServiceNow: Which Technology Stock Is a Better Buy for 2027?3:43:02 PM ETGOOGL$280.75-8.28(-2.86%)BREAKINGVIEWS-Global muscle will sift puny data center providers3:30:09 PM ETAMD$408.79-79.90(-16.35%)Is AMD Stock a Buy as AI Revenue Soars?3:19:00 PM ETGEV$769.00-63.51(-7.63%)GE Vernova vs. NextEra Energy: Which Industrials Stock Is a Better Buy for 2027?3:17:11 PM ETBRK-A$857,487.54-9,063.79(-1.05%)Berkshire Hathaway Reports Nov. 7 With Its Stock at a Record. Its Cash Pile Is the Number to Watch.3:17:02 PM ETC$118.48+0.68(+0.58%)UPDATE 10-Brent crude jumps, settles up over $3 after tanker attacks3:15:37 PM ETCLX$99.50+0.30(+0.30%)Global Surface Disinfectant Market to Hit US$ 7.5 Bn by 2031, Registering at 7.4% CAGR: Wissen Research3:14:00 PM ETTM$215.73+16.37(+8.21%)ERI’s John Shegerian Describes the Current State of Rare Earth Mineral Recovery at World Remanufacturing Summit in Tokyo3:09:00 PM ETMRVL$134.70-25.21(-15.77%)Marvell Just Dropped 49% in a Month: Is MRVL Stock Hopeless or Ready for a Rebound?3:03:21 PM ETSPCX$123.59-12.24(-9.01%)Bull v. Bear: SPCX Faces Uncertainty as Midterm Results Pressure TSLA Merger3:00:38 PM ETINTC$52.26-6.02(-10.33%)Intel Shares Rise 6% To Intraday High After Key Trading Signal3:00:27 PM ETAMD$408.79-79.90(-16.35%)Advanced Micro Devices vs. Taiwan Semiconductor Manufacturing: The AI Sell-Off Is Exposing a Critical Difference Investors Shouldn't Ignore for 20273:00:02 PM ETHSY$177.43+2.93(+1.68%)Hershey vs. Coca-Cola: Which Consumer Goods Stock Is a Better Buy for 2027?2:51:29 PM ETCRWD$217.00-23.98(-9.95%)CrowdStrike Stock Plummets on AI Regulation Fears2:50:42 PM ETMETA$602.76-26.91(-4.27%)Meta says US users can now video chat with their Muse AI avatar2:48:28 PM ETWFC$84.74-2.72(-3.11%)UNCF Empower Me Tour Continues in Milwaukee, WI, on Nov. 10th with College Readiness Conference, Offering Scholarships and On-Site College Admissions2:43:35 PM ET

STLN · NASDAQ

Starling Oncology, Inc.

$6.32 -0.62 (-8.93%)

Company overview

Starling Oncology, Inc., formerly The Oncology Institute, is a value-based oncology company advancing cancer care in the community setting. Founded in 2007, the company offers cutting-edge, evidence-based cancer treatments, including clinical trials and transfusions, to a large patient population. It operates as an integrated oncology platform serving patients, providers, and health plans across multiple markets with a focus on delivering high-quality, patient-centered care.

Sector
Healthcare
Industry
Medical - Care Facilities
Exchange
NASDAQ
Market cap
$632M
Employees
641
Headquarters
Cerritos, CA
Website
starlingoncology.com
Listed
August 4, 2026
P/E
0.00
Dividend yield
0.00%

Price chart

4.765.375.996.617.22
STLN 1D NASDAQ O6.44H7.04L6.41C6.94+0.60 (+9.46%)Vol1.69M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
View
Ticker Type Headline Source Published
STLNStarling Oncology, Inc. Stock news BRIEF-Starling Oncology Q3 Net Income USD -15.7 Million Reuters
STLNStarling Oncology, Inc. Press release Starling Oncology Reports Third Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance GlobeNewswire
STLNStarling Oncology, Inc. Stock news Starling Oncology Reports Third Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance GlobeNewswire
STLNStarling Oncology, Inc. Press release Starling Oncology Announces Third Quarter 2026 Earnings Release Date and Conference Call GlobeNewswire
STLNStarling Oncology, Inc. Stock news Oncology Institute (NASDAQ:STLN) Shares Climb 6.1% – Should You Buy? Defense World
STLNStarling Oncology, Inc. Press release Starling Oncology Leadership Highlights Recent and Upcoming Industry Conference Participation GlobeNewswire
STLNStarling Oncology, Inc. Stock news Starling Oncology: Improving Cash Flow And Gross Profit Fuel A Re-Rating Seeking Alpha
STLNStarling Oncology, Inc. Press release Starling Oncology to Participate in Wells Fargo Healthcare Conference GlobeNewswire
STLNStarling Oncology, Inc. Press release Starling Oncology Launches Starling Nexus™, a Technology Platform Built to Optimize Oncology Provider Engagement and Accelerate High-Quality Care at Scale GlobeNewswire
STLNStarling Oncology, Inc. Stock news Starling Oncology, Inc. (STLN) Q2 2026 Earnings Call Transcript Seeking Alpha
STLNStarling Oncology, Inc. Stock news The Oncology Institute, Inc. (STLN) Reports Q2 Loss, Tops Revenue Estimates Zacks Investment Research
STLNStarling Oncology, Inc. Press release The Oncology Institute Rebrands as Starling Oncology GlobeNewswire
See more
FAQ

Questions about Starling Oncology, Inc.

What does Starling Oncology, Inc. do?
Starling Oncology, Inc., formerly The Oncology Institute, is a value-based oncology company advancing cancer care in the community setting. Founded in 2007, the company offers cutting-edge, evidence-based cancer treatments, including clinical trials and transfusions, to a large patient population. It operates as an integrated oncology platform serving patients, providers, and health plans across multiple markets with a focus on delivering high-quality, patient-centered care.
What is STLN's market cap?
Starling Oncology, Inc. (STLN) is a listed stock with a live quote. The latest market cap on this page is $632M.
Where is Starling Oncology, Inc. headquartered?
Starling Oncology, Inc. is headquartered in Cerritos, CA.
How do I get STLN news from the API?
Call GET /v1/news?tickers=STLN. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.
How far back does STLN news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for STLN, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.
Is the STLN price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 250 REST requests a day, 1 WebSocket connection, 5 requests per second, and 2,500 WebSocket messages a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs